Free daily briefing on global business news.
The average of price targets set by Wall Street analysts indicates a potential upside of 47.1% in Nutex Health (NUTX). While the effectiveness of this highly so
Shares of Nutex Health Inc. (NUTX) have gained 26.2% over the past four weeks to close the last trading session at $187.6, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $276 indicates a potential upside of 47.1%.
The average comprises five short-term price targets ranging from a low of $200.00 to a high of $310.00, with a standard deviation of $43.93. While the lowest estimate indicates an increase of 6.6% from the current price level, the most optimistic estimate points to a 65.3% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.
While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice.
